Erste Group Bank Raises Eli Lilly's FY2027 Earnings Forecast

Equities researchers at Erste Group Bank increase their FY2027 EPS estimate for Eli Lilly and Company.

Mar. 27, 2026 at 12:36pm

Got story updates? Submit your updates here. ›

Equities researchers at Erste Group Bank have increased their FY2027 earnings per share (EPS) forecast for Eli Lilly and Company (NYSE:LLY). Erste Group Bank analyst H. Engel now expects the company to post earnings of $42.60 per share for the year, up from their previous estimate of $42.00 per share. The current consensus estimate for Eli Lilly's full-year earnings is $23.48 per share.

Why it matters

Earnings forecasts from major research firms can significantly impact investor sentiment and stock prices for pharmaceutical companies like Eli Lilly. This revised FY2027 outlook from Erste Group Bank suggests the firm sees strong long-term growth potential for Lilly's drug pipeline and commercial operations.

The details

In a research note issued to investors on March 24th, Erste Group Bank analyst H. Engel increased the firm's FY2027 EPS estimate for Eli Lilly from $42.00 to $42.60 per share. This revised forecast is well above the current consensus estimate of $23.48 per share for Lilly's full-year 2026 earnings.

  • Erste Group Bank issued the updated FY2027 earnings forecast on March 24, 2026.

The players

Erste Group Bank

An Austrian banking group that provides a range of financial services across Central and Eastern Europe.

H. Engel

An equities research analyst at Erste Group Bank who covers Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana that researches, develops, manufactures, and commercializes medicines and therapies for patients worldwide.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

The takeaway

This revised FY2027 earnings forecast from Erste Group Bank suggests the firm sees strong long-term growth potential for Eli Lilly, underscoring the pharmaceutical company's ability to continue developing innovative drugs and therapies that could drive future financial performance.